$34.9 Million is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 35 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MSFT | New | MICROSOFT CORP | $1,473,000 | – | 23,707 | +100.0% | 4.22% | – |
MBBYF | New | MOBILEYE | $213,000 | – | 5,600 | +100.0% | 0.61% | – |
FFIN | New | FIRST FINL BANKSHARES INC | $104,000 | – | 2,300 | +100.0% | 0.30% | – |
PSX | New | PHILLIPS 66 | $50,000 | – | 575 | +100.0% | 0.14% | – |
BWXT | New | BWX TECHNOLOGIES | $20,000 | – | 513 | +100.0% | 0.06% | – |
HAL | New | HALLIBURTON CO | $18,000 | – | 324 | +100.0% | 0.05% | – |
BMY | New | BRISTOL-MYERS SQUIBB CO. | $16,000 | – | 268 | +100.0% | 0.05% | – |
WFC | New | WELLS FARGO COMPANY(NEW) | $6,000 | – | 113 | +100.0% | 0.02% | – |
ALXN | New | ALEXION PHARMACEUTICALS INC | $5,000 | – | 40 | +100.0% | 0.01% | – |
HTH | New | HILLTOP HOLDINGS INC | $5,000 | – | 173 | +100.0% | 0.01% | – |
ETP | New | ENERGY TRANSFER PARTNERS LPlp - public equity | $5,000 | – | 135 | +100.0% | 0.01% | – |
BW | New | BABCOCK & WILCOX | $4,000 | – | 255 | +100.0% | 0.01% | – |
SON | New | SONOCO PRODUCTS INC | $4,000 | – | 85 | +100.0% | 0.01% | – |
GE | New | GENERAL ELECTRIC CO | $3,000 | – | 100 | +100.0% | 0.01% | – |
YUM | New | YUM! BRANDS INC | $3,000 | – | 50 | +100.0% | 0.01% | – |
SXC | New | SUNCOKE ENERGY INC | $2,000 | – | 136 | +100.0% | 0.01% | – |
VB | New | VANGUARD SMALL-CAP ETF | $2,000 | – | 19 | +100.0% | 0.01% | – |
VZ | New | VERIZON COMMUNICATIONS INC | $2,000 | – | 40 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-07
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
TEXAS INSTRUMENTS INC | 44 | Q2 2024 | 31.2% |
PORTLAND GENERAL ELECTRIC CO | 41 | Q2 2024 | 0.0% |
LEXICON PHARMACEUTICALS INC | 36 | Q2 2024 | 1.7% |
AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
AILERON THERAPEUTICS INC | March 05, 2024 | 1,812,627 | 6.2% |
Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-09-17 |
N-PX | 2024-09-03 |
13F-HR/A | 2024-08-29 |
13F-HR/A | 2024-08-29 |
13F-HR/A | 2024-08-29 |
13F-HR/A | 2024-08-29 |
13F-HR/A | 2024-08-29 |
13F-HR | 2024-08-01 |
4 | 2024-06-17 |
4 | 2024-06-12 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.